ArticleNanomedicine (London, England)2025

Tissue engineering with targeted delivery of nanotized S-nitrosyl mutant of NEMO ameliorates myocardial infarction.

Abhik Kar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.